Molina Healthcare, Inc (NYSE:MOH - Get Free Report) COO James Woys acquired 10,000 shares of the firm's stock in a transaction dated Monday, August 4th. The stock was purchased at an average cost of $155.94 per share, with a total value of $1,559,400.00. Following the transaction, the chief operating officer owned 74,331 shares in the company, valued at approximately $11,591,176.14. This trade represents a 15.54% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available at this hyperlink.
Molina Healthcare Stock Performance
NYSE MOH traded up $1.87 during trading on Friday, reaching $156.87. The company's stock had a trading volume of 1,308,298 shares, compared to its average volume of 2,306,302. The company has a current ratio of 1.66, a quick ratio of 1.66 and a debt-to-equity ratio of 0.77. The firm has a market capitalization of $8.50 billion, a price-to-earnings ratio of 7.73 and a beta of 0.52. Molina Healthcare, Inc has a 12 month low of $151.95 and a 12 month high of $365.23. The firm has a 50 day moving average price of $236.76 and a 200 day moving average price of $286.88.
Molina Healthcare (NYSE:MOH - Get Free Report) last posted its quarterly earnings data on Wednesday, July 23rd. The company reported $5.48 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $5.50 by ($0.02). The business had revenue of $11.43 billion during the quarter, compared to the consensus estimate of $10.94 billion. Molina Healthcare had a net margin of 2.60% and a return on equity of 27.72%. The business's revenue for the quarter was up 15.7% on a year-over-year basis. During the same period in the prior year, the firm earned $5.86 EPS. As a group, equities analysts anticipate that Molina Healthcare, Inc will post 24.4 EPS for the current fiscal year.
Institutional Trading of Molina Healthcare
Institutional investors have recently bought and sold shares of the business. Price T Rowe Associates Inc. MD lifted its holdings in shares of Molina Healthcare by 46.4% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 3,838,043 shares of the company's stock worth $1,264,214,000 after acquiring an additional 1,216,903 shares during the period. GAMMA Investing LLC lifted its holdings in shares of Molina Healthcare by 74,593.7% during the 1st quarter. GAMMA Investing LLC now owns 667,015 shares of the company's stock worth $219,708,000 after acquiring an additional 666,122 shares during the period. FMR LLC lifted its holdings in shares of Molina Healthcare by 31.1% during the 4th quarter. FMR LLC now owns 1,801,113 shares of the company's stock worth $524,214,000 after acquiring an additional 427,276 shares during the period. Voloridge Investment Management LLC lifted its holdings in shares of Molina Healthcare by 1,641.3% during the 4th quarter. Voloridge Investment Management LLC now owns 409,807 shares of the company's stock worth $119,274,000 after acquiring an additional 386,273 shares during the period. Finally, Invesco Ltd. lifted its holdings in shares of Molina Healthcare by 28.5% during the 4th quarter. Invesco Ltd. now owns 1,327,021 shares of the company's stock worth $386,229,000 after acquiring an additional 294,180 shares during the period. Institutional investors own 98.50% of the company's stock.
Wall Street Analysts Forecast Growth
A number of brokerages have recently commented on MOH. Sanford C. Bernstein began coverage on shares of Molina Healthcare in a research report on Tuesday, April 22nd. They issued an "outperform" rating and a $414.00 price objective for the company. Truist Financial reissued a "hold" rating and issued a $180.00 price objective (down previously from $335.00) on shares of Molina Healthcare in a research report on Friday, July 25th. Morgan Stanley downgraded shares of Molina Healthcare from an "overweight" rating to an "equal weight" rating and reduced their target price for the stock from $364.00 to $266.00 in a report on Thursday, July 10th. Robert W. Baird reduced their target price on shares of Molina Healthcare from $373.00 to $179.00 and set a "neutral" rating for the company in a report on Friday, July 25th. Finally, Baird R W downgraded shares of Molina Healthcare from a "strong-buy" rating to a "hold" rating in a report on Tuesday, April 15th. Eleven research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat.com, Molina Healthcare presently has an average rating of "Hold" and a consensus target price of $244.55.
Read Our Latest Stock Report on Molina Healthcare
Molina Healthcare Company Profile
(
Get Free Report)
Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.
Featured Articles
Before you consider Molina Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Molina Healthcare wasn't on the list.
While Molina Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.